Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab

Table 2

Correlations between observed changes in mean foveal thickness and observed changes in other parameters for the entire study group and Subgroup A.

Variable	Entire group		Subgroup A
	r	P value	r	P value
CDVA	−0.311*	0.042 ^†	−0.569*	0.027
ROS fixation	−0.411**	0.008	−0.500	0.069
ROS central 5°	−0.592**	<0.001	−0.611*	0.020
ROS central 16°	−0.536**	<0.001	−0.554*	0.040
logRAD	0.182	0.242	0.505	0.055
Reading speed	0.105	0.501	0.537	0.039 *
Mean reading speed	−0.259	0.307	0.033	0.908
LogCSmesopic_1.5cpd	−0.122	0.440	0.133	0.651
LogCSmesopic_3cpd	−0.073	0.645	−0.058	0.843
LogCSmesopic_6cpd	−0.091	0.569	0.193	0.508
LogCSmesopic_12cpd	−0.005	0.973	0.459	0.098
LogCSmesopic_18cpd	−0.041	0.797	0.327	0.254
LogCSphotopic_1.5cpd	0.001	0.997	0.066	0.823
LogCSphotopic_3cpd	−0.087	0.586	−0.086	0.770
LogCSphotopic_6cpd	0.018	0.910	−0.022	0.939
LogCSphotopic_12cpd	−0.165	0.296	0.000	0.999
LogCSphotopic_18cpd	−0.147	0.352	0.260	0.369
LogGDmesopic_1.5cpd	−0.334*	0.031	−0.167	0.569
LogGDmesopic_3cpd	−0.344*	0.026	−0.206	0.481
LogGDmesopic_6cpd	−0.108	0.494	0.018	0.951
LogGDmesopic_12cpd	0.001	0.997	0.418	0.137
LogGDmesopic_18cpd	−0.348*	0.024	−0.246	0.397
LogGDphotopic_1.5cpd	0.166	0.294	0.313	0.277
LogGDphotopic_3cpd	0.157	0.322	0.488	0.077
LogGDphotopic_6cpd	−0.065	0.683	−0.125	0.671
LogGDphotopic_12cpd	−0.208	0.187	0.078	0.792
LogGDphotopic_18cpd	−0.220	0.161	0.140	0.634

Abbreviations: CDVA: corrected-distance visual acuity; ROS: retinotopic ocular sensitivity; CS: contrast sensitivity; mesopic/photopic: under mesopic/photopic conditions; cpd: cycles per degree; GD: glare disability.
*Correlation significant at the 0.05 level (2 tailed).
**Correlation significant at the 0.01 level (2 tailed).
^†Removal of one outlier.